Burrobrush (Nelco Laboratories, Inc.)


Welcome to the PulseAid listing for the Burrobrush drug offered from Nelco Laboratories, Inc.. This Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Nelco Laboratories, Inc.
NON-PROPRIETARY NAME: Burrobrush
SUBSTANCE NAME: HYMENOCLEA SALSOLA POLLEN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]
ROUTE: INTRADERMAL; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1972-08-29
END MARKETING DATE: 0000-00-00


Burrobrush HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBurrobrush from Nelco Laboratories, Inc.
LABELER NAME: Nelco Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10000([PNU]/mL)
START MARKETING DATE: 1972-08-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 36987-3149_45a21265-75ff-4634-a154-faff541e45d6
PRODUCT NDC: 36987-3149
APPLICATION NUMBER: BLA102192

Other HYMENOCLEA SALSOLA POLLEN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Nelco Laboratories, Inc.Burrobrush